Merck entered into an agreement with Avanti® Polar Lipids to be the exclusive multinational distributor of research lipids portfolio. Under the terms of the agreement, Merck will utilize Merck’s marketing and e-commerce platform to distribute Avanti® Polar Lipids research lipid portfolio. In Korea, distribution starts from 1st of March, 2018.
Avanti® Polar Lipids is a leading manufacturer and supplier of the highest purity lipids for research and pharmaceutical product development. Through this agreement, customers will have enhanced, on-demand access to the Avanti® research lipid portfolio through the life science business of Merck’s robust e-commerce platform, SigmaAldrich.com. Transition of approximately 2,000 products from the Avanti® research lipid portfolio to Merck is completed on 1st, March 2018 and customers can order through Merck Korea.
“High-quality lipids are an essential component of precision in the laboratory,” said Klaus Bischoff, Head of the Research Solutions business area, Life Science at Merck. “Avanti® Polar Lipids’ research lipids strengthen Merck’s overall Life Science portfolio, giving our customers access to a broad portfolio of the highest purity lipids on the market.”
Merck offers a complete portfolio of products and solutions that enable scientific discovery, including life science reagents and kits, lab and specialty chemicals and lab separation and workflow tools.
